Skip to main content
. Author manuscript; available in PMC: 2009 Oct 28.
Published in final edited form as: Clin Pharmacol Ther. 2007 Oct 31;82(6):700–710. doi: 10.1038/sj.clpt.6100409

Figure 4.

Figure 4

Survival and individual tumor volume in SCID mice bearing subcutaneous KAS-6/1 multiple myeloma xenografts treated with various doses of MV-NIS. (a) Survival proportions (UV-inactivated, black; 104 TCID50, red; 105 TCID50, blue; 106 TCID50, green; 107 TCID50, purple). Individual tumor volumes plotted for mice treated with (b) UV-inactivated, (c) 104 TCID50, (d) 105 TCID50, (e) 106 TCID50, and (f) 107 TCID50 MV-NIS.